SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-155396
Filing Date
2013-04-16
Accepted
2013-04-15 19:31:10
Documents
4
Period of Report
2013-05-31
Effectiveness Date
2013-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d519965ddef14a.htm DEF 14A 521953
2 GRAPHIC g519965g19s15.jpg GRAPHIC 10241
3 GRAPHIC g519965img1.jpg GRAPHIC 122014
4 GRAPHIC g519965img2.jpg GRAPHIC 79210
  Complete submission text file 0001193125-13-155396.txt   814784
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 13762402
SIC: 2836 Biological Products, (No Diagnostic Substances)